Figure 6.
Immunohistochemical features of the lesions included in the differential diagnosis of PA with extensive squamous metaplasia
| Antibody Specificity | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lesion | CK 7 | CK 8 | CK 19 | CK 20 | Hmw CKs | EMA | CEA | GFAP | S-100 | SMA | MSA | p63 | Vim |
| PA | + | + | + | - | + | + | + | + | + | + | + | + | + |
| MEC | + | + | + | - | + | + | a | + | - | - | - | a | - |
| SCC | - | + | a | - | + | + | + | Nf | - | - | nf | a | - |
| KC | + | - | + | nf | nf | nf | nf | Nf | - | - | nf | nf | nf |
PA (Pleomorphic adenoma), MEC (Mucoepidermoid carcinoma), SCC (Squamous cell carcinoma), KC (Keratocystoma), Vim (Vimentin)
(-) negative; (+) positive; (a) variable expression; (nf) data not found